A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil
Transfusion Medicine · 2025-02 · 35 (1) · 91-96
DOI: 10.1111/tme.13119 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transfusion Medicine, online erschienen am 12.12.2024. Verfasst von Dante M Langhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, HHemo Institute of Education, São Paulo, Brazil. Hauptthemen laut MEDLINE: Blood Donors, Chikungunya Fever, Chikungunya virus, Dengue. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Roche.
Abstract (Originalsprache)
Background and Objectives Arboviruses outbreaks are increasing in their frequency, geographical area and extension. Brazil is one of the most affected countries in the world, due to its tropical weather and favourable mosquito proliferation conditions. During outbreaks, the safety of the blood supply is a concern, in spite of the low number of transfusion‐transmitted cases with clinical impact. The aim of this study was to evaluate the use of NAT for Dengue, Zika and Chikungunya RNA in actual screening. Materials and Methods Blood donors from services located in 4 Brazilian regions were invited to participate in the study and provide an extra blood sample during the collection period between February 7, 2020, and April 4, 2020. Plasma from 21 341 donations was tested in mini pools of 6 by a duplex NAT for Dengue and Chikungunya, in addition to a Zika single assay. Confirmed viremic samples were submitted to an alternative NAT and serological assays.
Results
There were 33 (0.15%) Dengue RNA+ and 5 (0.02%) Chikungunya RNA+ donations. The South region showed the highest prevalence of Dengue‐infected donors (0.29%). These results are in line with the incidence of these arboviruses on the respective geographical regions. Viremic units were discarded and blood services notified.
Conclusion
Screening blood donors for arboviruses during the outbreak season in Brazil reveals a significant number of viremic individuals. Arbovirus NAT testing is feasible and may be incorporated to the current screening policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, HHemo Institute of Education, São Paulo, Brazil.
- Clinical and Experimental Oncology Department, Hematology and Hemotherapy Division, College of Medicine of the Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil.
- Laboratório de Investigação Médica em Virologia (LIM-52), Instituto de Medicina Tropical da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
- Imunolab Laboratory, São Paulo, Brazil.
ORCID-Profile: José E Levi
Förderung
- Roche
Zitieren
APA
Langhi, D. M., Levi, J. E., Sanches, S., Cerqueira, R. S., Felix, A. C., Ribeiro, G., & Bordin, J. O. (2025). A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil. Transfusion Medicine, 35(1), 91-96. https://doi.org/10.1111/tme.13119
Vancouver
Langhi DM, Levi JE, Sanches S, Cerqueira RS, Felix AC, Ribeiro G, et al. A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil. Transfusion Medicine. 2025;35(1):91-96. doi:10.1111/tme.13119
BibTeX
@article{Langhi2025,
author = {Langhi, Dante M and Levi, José E and Sanches, Sidneia and Cerqueira, Renato S and Felix, Alvina Clara and Ribeiro, Glaciano and Bordin, José O},
title = {A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil},
journal = {Transfusion Medicine},
year = {2025},
volume = {35},
number = {1},
pages = {91--96},
doi = {10.1111/tme.13119}
}
EUVIMED